PreveCeutical Medical Inc. (FRA:18H0)
Germany
· Delayed Price · Currency is EUR 0.0122
+0.0009 (7.96%)
At close: Dec 4, 2025
PreveCeutical Medical Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -3.12 | -1.17 | -1.27 | -1.48 | -1.73 | -3.8 | Upgrade
|
| Depreciation & Amortization | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.08 | Upgrade
|
| Other Amortization | - | - | - | - | - | 0 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | -0 | 0 | 0.08 | Upgrade
|
| Stock-Based Compensation | 0.78 | 0.08 | 0.13 | 0.33 | 0.09 | 1.17 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | 0.04 | - | - | Upgrade
|
| Other Operating Activities | 0.31 | 0.32 | 0.31 | 0.38 | 0.61 | 1.84 | Upgrade
|
| Change in Accounts Receivable | 0.01 | -0.02 | 0.01 | -0 | 0.04 | 0.01 | Upgrade
|
| Change in Accounts Payable | 0.86 | 0.34 | 0.53 | 0.52 | 0.55 | 0.49 | Upgrade
|
| Change in Other Net Operating Assets | -0.11 | 0.03 | -0.02 | -0.03 | 0.01 | 0.21 | Upgrade
|
| Operating Cash Flow | -1.25 | -0.43 | -0.3 | -0.22 | -0.43 | 0.06 | Upgrade
|
| Capital Expenditures | -0 | -0 | - | - | - | - | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0 | 0 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0 | - | - | - | -0.06 | -0 | Upgrade
|
| Investing Cash Flow | -0.01 | -0 | - | 0 | -0.05 | -0 | Upgrade
|
| Short-Term Debt Issued | - | 0.32 | 0.29 | 0.22 | 0.19 | 0.06 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 0.09 | 0.17 | Upgrade
|
| Total Debt Issued | 0.08 | 0.32 | 0.29 | 0.22 | 0.28 | 0.23 | Upgrade
|
| Short-Term Debt Repaid | - | -0.07 | - | - | -0.14 | -0.01 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | - | -0.04 | Upgrade
|
| Total Debt Repaid | -0.1 | -0.07 | - | - | -0.14 | -0.05 | Upgrade
|
| Net Debt Issued (Repaid) | -0.02 | 0.25 | 0.29 | 0.22 | 0.14 | 0.18 | Upgrade
|
| Issuance of Common Stock | 1.41 | 0.24 | - | - | - | 0 | Upgrade
|
| Other Financing Activities | - | - | - | -0.01 | - | - | Upgrade
|
| Financing Cash Flow | 1.39 | 0.49 | 0.29 | 0.21 | 0.14 | 0.18 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.03 | -0 | -0 | -0 | 0.2 | -0.12 | Upgrade
|
| Net Cash Flow | 0.1 | 0.06 | -0 | -0.01 | -0.14 | 0.13 | Upgrade
|
| Free Cash Flow | -1.26 | -0.43 | -0.3 | -0.22 | -0.43 | 0.06 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | - | -0.00 | - | Upgrade
|
| Cash Interest Paid | 0.01 | 0.01 | 0 | 0 | 0 | 0.01 | Upgrade
|
| Levered Free Cash Flow | -0.13 | -0.25 | -0.1 | -0.25 | -0.29 | -0.02 | Upgrade
|
| Unlevered Free Cash Flow | 0.07 | -0.04 | 0.1 | -0.1 | 0 | 0.38 | Upgrade
|
| Change in Working Capital | 0.76 | 0.34 | 0.53 | 0.49 | 0.59 | 0.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.